2 Monster Stocks in the Making to Buy and Hold

Group 1: SoFi Technologies - SoFi Technologies is a growing online financial services company with a customer base of 12.6 million, reflecting a 35% year-over-year increase [3][6] - The company is expanding its product offerings, including reentering the crypto trading market and cross-selling services, currently averaging 1.5 products per member [4][6] - SoFi targets high-credit-score individuals for personal loans, with an average credit score of 745 among borrowers, positioning itself as a future-oriented bank [7] Group 2: Summit Therapeutics - Summit Therapeutics is developing ivonescimab, a cancer therapy that has outperformed Merck's Keytruda in clinical trials for advanced non-small cell lung cancer (NSCLC) [8][11] - The oncology market is significant, with NSCLC being a major contributor to cancer mortality, representing about 85% of lung cancer cases [9] - Summit holds rights to ivonescimab in most markets outside China, with potential annual sales projected at $53 billion at peak [11][12]